Description: A health innovation team is developing a mobile app for patients with prostate cancer to help facilitate treatments and enhance the quality of life. They know how critical it is to hear directly from patients while they are in the ideation and development stage. The team would like to conduct a 30-minute phone interview with selected applicants between November …
Savvy Cooperative: Multiple Paid Opportunities for Current Cancer Patients and Survivors
Savvy Cooperative is the first and only patient-owned co-op that empowers people to use their health experiences to inform new products and services through surveys, interviews, product testing and more! It was founded by two patients who wanted to make sure people who shared their health experiences were fairly compensated. That’s why we are patient-owned and the majority of our …
Quest for new cancer treatment crosses milestone
Source: Rice University From: sciencedaily.com A cancer therapy has crossed a milestone in clinical trials, a major development in a decades-long quest to develop a treatment that destroys tumors without the debilitating side effects of chemotherapy, invasive surgery and radiation. A cancer therapy invented at Rice University has crossed a milestone in clinical trials, a major development in a decadeslong …
UT Southwestern Researchers find evidence a cancer drug may be extended to many more patients
Source: UT Southwestern Medical Center From: PR Newswire A new molecular mechanism discovered by UT Southwestern researchers indicates that drugs currently used to treat less than 10 percent of breast cancer patients could have broader effectiveness in treating all cancers where the drugs are used, including ovarian and prostate cancers. The new study also revealed a potential biomarker indicating when …
Breast cancer gene mutation clinical trial to take place in Australia
By: Meagan Dillon and Leah MacLennan From: abc.net.au Breast cancer is a disease that predominantly impacts women, but it is not unheard of for men to also carry a rare genetic mutation that significantly increases the risk. Helen Hicks’s husband Tony Ransom is in that category — but the Adelaide couple will not know if the mutation has been passed …
His single-cell solution is revolutionizing cancer research
By: Clayton Boldt, Ph.D. From: mdanderson.org Nicholas Navin wanted to better understand how tumors grow and evolve, so he found a way to analyze the DNA of individual cells Frustration often leads to innovation. Thomas Edison himself called discontent the “first necessity of progress.” For Nicholas Navin, Ph.D., it drove him to pioneer a technique that has revolutionized the way researchers are able …
Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR Meeting
Source: Constellation Pharmaceuticals , Inc. From: globenewswire.com Clinical activity of CPI-1205 was seen in subsets of advanced metastatic castration-resistant prostate cancer (mCRPC) patients Recently initiated Phase 2 portion of ProSTAR includes randomized testing of CPI-1205 in combination with enzalutamide versus enzalutamide alone, as well as CPI-1205 in combination with abiraterone Initial update from Phase 2 portion of ProSTAR expected in …
FDA Warns About Robotic Mastectomy, Other Surgeries
By: Nick Mulcahy From: medscape.com The US Food and Drug Administration (FDA) today issued a safety communication to healthcare providers about the use of robotically assisted surgical devices for mastectomy and other cancer-related surgeries that are not already FDA approved. The agency urged caution about any such use. Robotic devices are approved for use in prostate cancer but not in most …
Racial disparities in US cancer deaths are shrinking, study finds
Posted By: CNN Wire From: wtvr.com Racial disparities in cancer deaths between black and white patients in the United States are receding — but more progress is needed to completely close the gap for some cancer types and age groups, according to a new study. Among men, the overall cancer death rate was 47% higher for blacks than for whites …
Veru Initiates Clinical Trial for Proprietary, Novel, First-in-Class Drug for Advanced Prostate Cancer
Source: Veru, Inc. From: globenewswire.com Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that it has initiated and enrolled the first patient in a clinical trial of its proprietary, next generation prostate cancer drug, VERU-111. The open-label Phase 1b/2 clinical trial for VERU-111, a novel oral drug, will be evaluated in men with metastatic refractory prostate …